Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vanda Pharmaceuticals
Biotech
Vanda receives FDA rejection, issues fiery response
The biotech came out swinging after the blow, accusing the FDA of sending a complete response letter that generally disregarded the evidence.
Nick Paul Taylor
Sep 19, 2024 8:02am
Vanda Pharmaceuticals shares in the red as phase 3 flops
Feb 26, 2020 7:50am
FDA wins legal dispute with Vanda over partial clinical hold
Feb 4, 2020 8:30am
FDA snubs jet lag filing for Hetlioz, 'perplexing' Vanda
Aug 19, 2019 10:20am
Vanda's atopic dermatitis drug misses mark in ph2 trial
Sep 14, 2017 6:09am
Biotech IPOs; CHMP knockbacks—News of Note
Jul 21, 2017 8:25am
